Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Driving Business Growth in B2B Marketing: The Game-Changing Impact of the Creator Economy

B2B brands in the healthcare industry are increasingly leveraging creator economy partnerships to build credibility and drive revenue growth. The article explores how thought leaders and content creators can serve as strategic assets in crowded B2B marketplaces. Creator-led strategies are emerging as a differentiator for healthcare organizations seeking authentic audience engagement.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Experts Talk on MarketScale.

By Experts Talk · BlitzmetricsCreator EconomyDavid KempDennis Yu
Share

Key takeaways

01

B2B healthcare brands are partnering with creators to establish credibility in competitive markets.

02

The creator economy is reshaping how B2B companies approach demand generation and revenue growth.

03

Authentic creator content can accelerate trust-building with healthcare decision-makers and buyers.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Influencer marketing is no longer just for consumer brands. In a report titled Influencing Business: The Global Rise of B2B Influencer Marketing, Ogilvy estimates that the global market size has expanded over 20 times since 2016! And with the creator economy projected to reach $500 billion by 2027, businesses are taking note. Social platforms like YouTube, Instagram, and TikTok, boasting nearly 5 billion monthly active users, have fueled this rise of the creator economy. The question is, how can the B2B marketing sector leverage this trend to build trust and drive business impact?

And with the creator economy projected to reach $500 billion by 2027, businesses are taking note.

In the latest episode of Experts Talk, host Gabrielle Bejarano dives into this topic with guests David Kemp, Healthcare Lead at MarketScale, and Dennis Yu, CTO of BlitzMetrics. They explore the evolving landscape of influencer marketing and its growing importance in the B2B marketing sector.

Key discussion points include:

– The exponential growth and potential of influencer marketing in B2B.

– The importance of selecting credible influencers to build trust.

– How leveraging employee influencers can be a game-changer.

David Kemp's career spans from coaching college basketball to aiding major healthcare systems with ICD-10 transitions. Kemp now hosts the Highway to Health podcast series and leads the healthcare vertical at MarketScale.

Dennis Yu is the CEO of BlitzMetrics, a digital marketing company that collaborates with schools to train young adults in the field. He has extensive experience in managing high-profile campaigns for clients like The Golden State Warriors and Nike, and is also an internationally recognized lecturer who has spoken at over 730 events across 17 countries.

Experts Talk

Part of this channel

Experts Talk

Industry experts debate the ideas that drive B2B decisions.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

ET
Experts Talk
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

ET
Experts Talk

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512